Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enzyme studies in human prostatic tissues.

N Deshpande, I Mitchell, J Towler

    Clinical Oncology
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Enzyme activity in prostate cancer differs from benign conditions. Specific carbohydrate metabolism enzymes like phosphofructokinase (PFK) show lower activity in carcinomas, potentially aiding in disease prediction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safety of maintaining elective and emergency surgery during the COVID-19 pandemic with the introduction of a Protected Elective Surgical Unit (PESU): A cross-specialty evaluation of 30-day outcomes in 9,925 patients undergoing surgery in a University Health Board.

    Surgery open science·2022
    Same author

    Erratum: "DFTB+, a software package for efficient approximate density functional theory based atomistic simulations" [J. Chem. Phys. 152, 124101 (2020)].

    The Journal of chemical physics·2022
    Same author

    Nonfuel Antineutrino Contributions in the High Flux Isotope Reactor.

    Physical review. C·2020
    Same author

    DFTB+, a software package for efficient approximate density functional theory based atomistic simulations.

    The Journal of chemical physics·2020
    Same author

    Extraction of the ^{235}U and ^{239}Pu Antineutrino Spectra at Daya Bay.

    Physical review letters·2019
    Same author

    Measurement of the Electron Antineutrino Oscillation with 1958 Days of Operation at Daya Bay.

    Physical review letters·2019
    Same journal

    Teaching ward nurses to monitor cancer patients.

    Clinical oncology·1984
    Same journal

    Fine needle aspiration breast cytology in district general hospital practice.

    Clinical oncology·1984
    Same journal

    A clinical assessment of loading dose tamoxifen for advanced breast carcinoma.

    Clinical oncology·1984
    Same journal

    Nasopharyngeal carcinoma in Malaysians under the age of 20 years.

    Clinical oncology·1984
    Same journal

    Oral urea in the treatment of colo-rectal liver metastases.

    Clinical oncology·1984
    Same journal

    Gastric remnant recurrence--detection and implications for the management of gastric cancer.

    Clinical oncology·1984
    See all related articles

    Area of Science:

    • Biochemistry
    • Oncology
    • Metabolic pathways

    Background:

    • Prostate cancer is a significant health concern.
    • Understanding metabolic alterations in prostate cancer is crucial for diagnosis and prognosis.
    • Carbohydrate metabolism plays a key role in cellular function and disease progression.

    Purpose of the Study:

    • To investigate enzyme activities related to carbohydrate metabolism in benign prostatic hyperplasia and prostate carcinoma.
    • To determine if these enzyme activities can predict the clinical course of prostate cancer.
    • To compare metabolic profiles between benign and malignant prostate tissues.

    Main Methods:

    • Enzyme activity assays were performed on tissue samples.
    • Six key enzymes involved in carbohydrate metabolism were quantified.

    Related Experiment Videos

  • Samples included 24 benign prostatic hyperplasias and 29 prostate carcinomas.
  • Enzyme activities were compared between different groups, including well-differentiated and poorly-differentiated carcinomas.

    • Main Results:

    • Activities of phosphofructokinase (PFK), alpha-glycerophosphate dehydrogenase (alpha-GPDH), and phosphohexose isomerase (PHI) were significantly lower in prostate carcinomas compared to benign tissues.
    • Poorly-differentiated carcinomas exhibited significantly lower 6-phosphogluconate dehydrogenase (6PGDH) activity and higher alpha-GPDH/6PGDH ratios compared to well-differentiated carcinomas.
    • These metabolic changes in prostate cancer were opposite to those observed in breast cancer.

    Conclusions:

    • Enzyme activity patterns in carbohydrate metabolism differ between benign and malignant prostate tissues.
    • Specific enzyme alterations, such as decreased PFK, alpha-GPDH, and PHI, are characteristic of prostate carcinomas.
    • The ratio of alpha-GPDH/6PGDH may serve as a potential biomarker for differentiating tumor grades and predicting clinical outcomes in prostate cancer.